| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.11B | 14.84B | 13.57B | 12.52B | 10.75B | 8.03B |
| Gross Profit | 6.74B | 7.19B | 6.97B | 6.54B | 5.08B | 4.06B |
| EBITDA | 1.34B | 1.15B | 1.65B | 1.90B | 998.62M | 1.49B |
| Net Income | 902.00M | 476.00M | 1.02B | 1.57B | 823.98M | 1.30B |
Balance Sheet | ||||||
| Total Assets | 13.68B | 16.11B | 13.98B | 11.86B | 9.68B | 8.44B |
| Cash, Cash Equivalents and Short-Term Investments | 9.02B | 10.56B | 9.79B | 7.95B | 6.26B | 5.73B |
| Total Debt | 1.25B | 1.78B | 1.26B | 44.00M | 279.78M | 359.35M |
| Total Liabilities | 3.81B | 5.44B | 3.68B | 2.36B | 1.94B | 1.86B |
| Stockholders Equity | 9.87B | 10.66B | 10.29B | 9.50B | 7.74B | 6.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.29B | 934.00M | 1.79B | 630.11M | 1.14B |
| Operating Cash Flow | 0.00 | 1.35B | 1.01B | 1.88B | 807.28M | 1.19B |
| Investing Cash Flow | 0.00 | -534.00M | -260.00M | -326.00M | -1.29B | -1.39B |
| Financing Cash Flow | 0.00 | 624.00M | 720.00M | -224.00M | -62.44M | -180.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥25.27B | 10.08 | ― | 3.06% | -6.49% | 4.98% | |
76 Outperform | ¥152.57B | 14.81 | ― | 2.30% | 13.82% | 37.07% | |
74 Outperform | ¥24.16B | 16.06 | ― | 0.73% | 17.86% | 21.52% | |
73 Outperform | ¥46.48B | 18.47 | 17.50% | 2.88% | 5.62% | 3.81% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥17.81B | -16.73 | ― | ― | 9.82% | -32.60% | |
42 Neutral | ¥6.98B | -28.24 | ― | ― | -29.41% | 79.74% |